Luise Weigand

422 total citations
8 papers, 281 citations indexed

About

Luise Weigand is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Luise Weigand has authored 8 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Luise Weigand's work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Luise Weigand is often cited by papers focused on CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Luise Weigand collaborates with scholars based in Germany and United States. Luise Weigand's co-authors include Angela M. Krackhardt, D O'Connell, Martin Böttcher, Ying-Fon Chang, Andréas Mackensen, Steven Ringquist, David H Parma, Heiko Bruns, Regina Jitschin and Domenica Saul and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Luise Weigand

8 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luise Weigand Germany	6	131	109	91	39	31	8	281
Katja Srpan United Kingdom	6	109 0.8×	177 1.6×	99 1.1×	46 1.2×	18 0.6×	6	326
Helly Vernitsky Israel	8	103 0.8×	222 2.0×	93 1.0×	20 0.5×	13 0.4×	17	364
Olga M. Antón Spain	10	173 1.3×	284 2.6×	117 1.3×	110 2.8×	30 1.0×	15	494
Julia M. Laufer Switzerland	9	116 0.9×	203 1.9×	146 1.6×	36 0.9×	16 0.5×	9	349
Stephen P. Persaud United States	8	90 0.7×	366 3.4×	119 1.3×	36 0.9×	23 0.7×	16	472
Katharina Mattenheimer Germany	8	74 0.6×	140 1.3×	90 1.0×	12 0.3×	25 0.8×	10	271
Kym R. Garrod United States	10	101 0.8×	369 3.4×	78 0.9×	21 0.5×	25 0.8×	10	463
Amanpreet Kaur United States	6	164 1.3×	62 0.6×	104 1.1×	36 0.9×	13 0.4×	8	271
Akihiro Minami Japan	12	179 1.4×	77 0.7×	54 0.6×	50 1.3×	52 1.7×	21	331
Shunji Hirai Japan	6	124 0.9×	225 2.1×	158 1.7×	22 0.6×	16 0.5×	8	327

Countries citing papers authored by Luise Weigand

Since Specialization

Citations

This map shows the geographic impact of Luise Weigand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luise Weigand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luise Weigand more than expected).

Fields of papers citing papers by Luise Weigand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luise Weigand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luise Weigand. The network helps show where Luise Weigand may publish in the future.

Co-authorship network of co-authors of Luise Weigand

This figure shows the co-authorship network connecting the top 25 collaborators of Luise Weigand. A scholar is included among the top collaborators of Luise Weigand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luise Weigand. Luise Weigand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Wisskirchen, Karin, Theresa Asen, Luise Weigand, et al.. (2017). Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use. PLoS ONE. 12(8). e0182936–e0182936. 28 indexed citations

Wisskirchen, Karin, Janine Kah, Luise Weigand, et al.. (2017). Hepatitis B virus-specific T cell receptors with high functional avidity redirect T cells to eliminate HBV. Journal of Hepatology. 66(1). S29–S30. 1 indexed citations

Bruns, Heiko, Martin Böttcher, Luise Weigand, et al.. (2016). The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia. Leukemia. 31(2). 470–478. 87 indexed citations

Weigand, Luise, Sabine Mall, Richard Klar, et al.. (2012). Isolation of human MHC class II‐restricted T cell receptors from the autologous T‐cell repertoire with potent anti‐leukaemic reactivity. Immunology. 137(3). 226–238. 10 indexed citations

Weigand, Luise, Ingrid Schuster, Matthias Leisegang, et al.. (2009). A Single TCRα-Chain with Dominant Peptide Recognition in the Allorestricted HER2/neu-Specific T Cell Repertoire. The Journal of Immunology. 184(3). 1617–1629. 27 indexed citations

Han, Yanyan, Ingrid Schuster, Luise Weigand, et al.. (2009). Formin-like 1 (FMNL1) Is Regulated by N-terminal Myristoylation and Induces Polarized Membrane Blebbing. Journal of Biological Chemistry. 284(48). 33409–33417. 60 indexed citations

Krackhardt, Angela M., Ingrid Schuster, Luise Weigand, et al.. (2009). Transfer of Human T-Cell Receptors (TCR) Containing Murine Chimeric Constant Beta-Gamma-Chain Sequences Reduces the Risk of Mixed Heterodimers and Shows Enhanced in Vitro-Accumulation of TCR-Tranduced Effector Cells.. Blood. 114(22). 3583–3583. 1 indexed citations

Watson, Susan R., Ying-Fon Chang, D O'Connell, et al.. (2000). Anti-L-Selectin Aptamers: Binding Characteristics, Pharmacokinetic Parameters, and Activity Against an Intravascular Target In Vivo. Antisense and Nucleic Acid Drug Development. 10(2). 63–75. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact